CD80 and neoplasm: An alternative explanation is that PD-L1 mAb treatment may be altering the microenvironment towards a T cell suppressive state, however increases in CD80/86 expression on the tumor cells after PD-L1 treatment suggest direct K7M2 TIL inhibition.